Page 849 - Read Online

Favre et al. Plast Aesthet Res 2020;7:71 I http://dx.doi.org/10.20517/2347-9264.2020.149 Page 11 of 12

increasingly common. Although there are some possible complications to be aware of, most patients do
extremely well with this treatment. New uses for BoNT in this field are constantly arising and are worth
exploring further.

DECLARATIONS
Authors’ contributions
Conception and design of the work: Sherris D
Analysis and interpretation of data for the work: Favre N, Sherris D
Drafting the work and revising it critically for important intellectual content: Favre N, Sherris D
Final approval of the version to be published: Favre N, Sherris D

Availability of data and materials
The data that support the findings of this study are available from the corresponding author, upon
reasonable request.

Financial support and sponsorship
None.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
I (Nicole Favre) consent to use my pictures.

Copyright
© The Author(s) 2020.

REFERENCES
1. Clark RP, Berris CE. Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis. Plast Reconstr Surg
1989;84:353-5.
2. Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol 1992;18:17-21.
3. Ong AA, Sherris DA. Neurotoxins. Facial Plast Surg 2019;35:230-8.
4. American Society of Plastic Surgeons News Release. Plastic Surgery Statistics Report. Available from: https://www.plasticsurgery.org/
news/plastic-surgery-statistics. [Last accessed on 10 Nov 2020]
5. Berwick S, Humble Á. Older women’s negative psychological and physical experiences with injectable cosmetic treatments to the face. J
Women Aging 2017;29:51-62.
6. Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol 2000;43:249-59.
7. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991;324:1186-94.
8. Hexsel D, Brum C, do Prado DZ, et al. Field effect of two commercial preparations of botulinum toxin type A: a prospective, double-
blind, randomized clinical trial. J Am Acad Dermatol 2012;67:226-32.
9. Hexsel D, Soirefmann M, Porto MD, Siega C, Schilling-Souza J, Rodrigues TC. Fields of muscular and anhidrotic effects of 2 botulinum
toxin-A commercial preparations: a prospective, double-blind, randomized, multicenter study. Dermatol Surg 2015;41 Suppl 1:S110-8.
10. Cohn JE, Greco TM. Advanced techniques for the use of Neurotoxins in non-surgical facial rejuvenation. Aesthetic Plast Surg
2020;44:1788-99.
11. Rohrich RJ, Ghavami A, Crosby MA. The role of hyaluronic acid fillers (Restylane) in facial cosmetic surgery: review and technical
considerations. Plast Reconstr Surg 2007;120:41S-54.
12. Carruthers JD, Lowe NJ, Menter MA, Gibson J, Eadie N, Botox Glabellar Lines II Study Group. Double-blind, placebo-controlled study
of the safety and efficacy of botulinum toxin type A for patients with glabellar lines. Plast Reconstr Surg 2003;112:1089-98.
13. Beer JI, Sieber DA, Scheuer JF 3rd, Greco TM. Three-dimensional facial anatomy: structure and function as it relates to injectable